Prot #ES-301: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)

Project: Research project

Project Details

StatusActive
Effective start/end date10/14/1910/14/22

Funding

  • Medpace Clinical Research LLC (Prot #ES-301)
  • Eicos Sciences, Inc. (Prot #ES-301)